Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul:42:102185.
doi: 10.1016/j.msard.2020.102185. Epub 2020 May 7.

Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain

Paloma Montero-Escribano  1 , Jorge Matías-Guiu  1 , Patricia Gómez-Iglesias  1 , Jesús Porta-Etessam  1 , Vanesa Pytel  1 , Jordi A Matias-Guiu  2
Affiliations
Comment

Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain

Paloma Montero-Escribano et al. Mult Scler Relat Disord. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Comment on

References

    1. Burks J S, DeVald B L, Jankovsky L D, Gerdes J C. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science. 1980;209:933–934. - PubMed
    1. Chan JFW, Yuan S, Kok KH, To KK, Chu H, Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523. doi: 10.1016/S0140-6736(20)30154-9. - DOI - PMC - PubMed
    1. Giovannoni G. Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19. Mult. Scler. Relat. Disord. 2020;41 doi: 10.1016/j.msard.2020.102135. - DOI - PMC - PubMed
    1. Giovannoni G, Hawkes C, Lechner-Scott J, Levy M, Waubant E, Gold J. The COVID-19 pandemic and the use of MS disease-modifying therapies. Mult. Scler. Relat. Disord. 2020;39 - PMC - PubMed
    1. Matías-Guiu J, Porta-Etessam J, Lopez-Valdes E, Garcia-Morales I, Guerrero-Solá A, Matias-Guiu JA. Management of neurological care during the COVID-19 pandemic. Neurologia. 2020 doi: 10.1016/j.nrl.2020.04.001. - DOI - PMC - PubMed

Substances